Cara Therapeutics Inc (CARA) Q2 2020 Earnings Call Transcript

This is Jack Hildick-Smith with Stern Investor Relations, and welcome to Cara Therapeutics Second Quarter 2020 Financial Results and Update Conference Call. Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include statements concerning the expected timing of the data readouts from the company's ongoing clinical trials, the potential results of ongoing clinical trials, timing of future regulatory and development milestones of the company's product candidates including the company's projected time line for the submission of its first NDA, the potential for the company's product candidates to be alternatives in the therapeutic areas investigated, and the company's expected cash reach.